FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017678291> ?p ?o ?g. }

• W2017678291 abstract "The serine/threonine protein kinase ataxia telangiectasia mutated (ATM) is critical in maintaining genomic integrity. Upon DNA double-strand breaks, ATM phosphorylates key downstream proteins including p53 and BRCA1/2, thereby orchestrating complex signaling pathways involved in cell cycle arrest, DNA repair, senescence and apoptosis. Although sporadic mutation of ATM occurs rarely in breast cancer, the status of its protein expression and its clinical significance in breast cancer remain not well established. Our study was designed to investigate the influence of ATM protein in both tumor and cancer-associated stroma on clinical outcome in hormone-positive (HPBC) and hormone-negative (HNBC) early-stage breast cancer (EBC). Tissue microarrays (TMAs), containing formalin-fixed, paraffin-embedded resected tumors from two cohorts of patients (HPBC cohort: n = 130; HNBC cohort: n = 168) diagnosed at the Tom Baker Cancer Centre, Calgary, Canada, were analyzed for ATM protein expression using fluorescence immunohistochemistry (IHC) and automated quantitative analysis (AQUA). ATM expression levels were measured within the tumor as a whole (tATM) as indicated by pan-cytokeratin expression, tumor nuclear compartment (nATM) as indicated by both DAPI and pan-cytokeratin-positive results, and cancer-associated stroma (csATM) as indicated by vimentin-positive and pan-cytokeratin-negative results. ATM expression levels within these compartments were correlated with clinical outcome. While tATM and nATM were significantly lower in tumors compared to normal breast epithelial tissues, csATM was significantly higher than the corresponding normal tissue compartment. In addition, the median expression level of both tATM and nATM were two- to threefold lower (P <0.001) in HNBC than in HPBC. In both HNBC and HPBC cohorts, patients with low tATM, nATM and csATM tumors had significantly poorer survival outcomes than those with a high tATM, nATM and csATM, but this effect was more pronounced in HNBC. A multivariate analysis demonstrates that these biomarkers predict survival independent of tumor size and lymph node status, but only in the HNBC cohort (P <0.001). Low ATM protein expression in both malignant tumor and stromal compartments likely contributes to the aggressive nature of breast cancer and is an independent prognostic factor associated with worse survival in HNBC patients." @default.
• W2017678291 created "2016-06-24" @default.
• W2017678291 creator A5005926546 @default.
• W2017678291 creator A5016268576 @default.
• W2017678291 creator A5023283384 @default.
• W2017678291 creator A5024668584 @default.
• W2017678291 creator A5025307613 @default.
• W2017678291 creator A5035453779 @default.
• W2017678291 creator A5040191407 @default.
• W2017678291 creator A5046386901 @default.
• W2017678291 creator A5049060308 @default.
• W2017678291 creator A5078451650 @default.
• W2017678291 creator A5080487628 @default.
• W2017678291 date "2015-05-03" @default.
• W2017678291 modified "2023-10-18" @default.
• W2017678291 title "Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer" @default.
• W2017678291 cites W1975799119 @default.
• W2017678291 cites W1977923363 @default.
• W2017678291 cites W1987875441 @default.
• W2017678291 cites W1989790390 @default.
• W2017678291 cites W2000895546 @default.
• W2017678291 cites W2006637448 @default.
• W2017678291 cites W2009628240 @default.
• W2017678291 cites W2010089653 @default.
• W2017678291 cites W2013718737 @default.
• W2017678291 cites W2014580403 @default.
• W2017678291 cites W2019315793 @default.
• W2017678291 cites W2024073529 @default.
• W2017678291 cites W2034142957 @default.
• W2017678291 cites W2039892803 @default.
• W2017678291 cites W2047831502 @default.
• W2017678291 cites W2055091687 @default.
• W2017678291 cites W2071457560 @default.
• W2017678291 cites W2073109785 @default.
• W2017678291 cites W2078431196 @default.
• W2017678291 cites W2081562657 @default.
• W2017678291 cites W2088857928 @default.
• W2017678291 cites W2090019572 @default.
• W2017678291 cites W2094448088 @default.
• W2017678291 cites W2094815521 @default.
• W2017678291 cites W2096349461 @default.
• W2017678291 cites W2099231097 @default.
• W2017678291 cites W2105882193 @default.
• W2017678291 cites W2114843025 @default.
• W2017678291 cites W2118632896 @default.
• W2017678291 cites W2124792836 @default.
• W2017678291 cites W2125370645 @default.
• W2017678291 cites W2133260711 @default.
• W2017678291 cites W2133650808 @default.
• W2017678291 cites W2135726126 @default.
• W2017678291 cites W2139777089 @default.
• W2017678291 cites W2155318349 @default.
• W2017678291 cites W2164550834 @default.
• W2017678291 doi "https://doi.org/10.1186/s13058-015-0575-2" @default.
• W2017678291 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4453198" @default.
• W2017678291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25935535" @default.
• W2017678291 hasPublicationYear "2015" @default.
• W2017678291 type Work @default.
• W2017678291 sameAs 2017678291 @default.
• W2017678291 citedByCount "32" @default.
• W2017678291 countsByYear W20176782912016 @default.
• W2017678291 countsByYear W20176782912017 @default.
• W2017678291 countsByYear W20176782912018 @default.
• W2017678291 countsByYear W20176782912019 @default.
• W2017678291 countsByYear W20176782912020 @default.
• W2017678291 countsByYear W20176782912021 @default.
• W2017678291 countsByYear W20176782912022 @default.
• W2017678291 countsByYear W20176782912023 @default.
• W2017678291 crossrefType "journal-article" @default.
• W2017678291 hasAuthorship W2017678291A5005926546 @default.
• W2017678291 hasAuthorship W2017678291A5016268576 @default.
• W2017678291 hasAuthorship W2017678291A5023283384 @default.
• W2017678291 hasAuthorship W2017678291A5024668584 @default.
• W2017678291 hasAuthorship W2017678291A5025307613 @default.
• W2017678291 hasAuthorship W2017678291A5035453779 @default.
• W2017678291 hasAuthorship W2017678291A5040191407 @default.
• W2017678291 hasAuthorship W2017678291A5046386901 @default.
• W2017678291 hasAuthorship W2017678291A5049060308 @default.
• W2017678291 hasAuthorship W2017678291A5078451650 @default.
• W2017678291 hasAuthorship W2017678291A5080487628 @default.
• W2017678291 hasBestOaLocation W20176782911 @default.
• W2017678291 hasConcept C121608353 @default.
• W2017678291 hasConcept C126322002 @default.
• W2017678291 hasConcept C142724271 @default.
• W2017678291 hasConcept C143998085 @default.
• W2017678291 hasConcept C193270364 @default.
• W2017678291 hasConcept C204232928 @default.
• W2017678291 hasConcept C2779012181 @default.
• W2017678291 hasConcept C2780140570 @default.
• W2017678291 hasConcept C502942594 @default.
• W2017678291 hasConcept C530470458 @default.
• W2017678291 hasConcept C71924100 @default.
• W2017678291 hasConcept C86803240 @default.
• W2017678291 hasConceptScore W2017678291C121608353 @default.
• W2017678291 hasConceptScore W2017678291C126322002 @default.
• W2017678291 hasConceptScore W2017678291C142724271 @default.
• W2017678291 hasConceptScore W2017678291C143998085 @default.
• W2017678291 hasConceptScore W2017678291C193270364 @default.
• W2017678291 hasConceptScore W2017678291C204232928 @default.
• W2017678291 hasConceptScore W2017678291C2779012181 @default.

• next